Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade Gliomas
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jian L Campian, MD, PhD
National Cancer Institute (NCI)
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uab Comprehensive Cancer Center
Birmingham, Alabama, United States
- Johns Hopkins Oncology Center
Baltimore, Maryland, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Josephine Ford Cancer Center at Henry Ford Hospital
Detroit, Michigan, United States
- Washington University
St Louis, Missouri, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Wake Forest University Comprehensive Cancer Center
Winston-Salem, North Carolina, United States
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
- Abrams Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Hillman Cancer Center at University of Pittsburgh Cancer Institute
Pittsburgh, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Oct 2018
- Primary completion
- 30 Mar 2022
- Completion
- 3 Oct 2023
- Last update posted
- 6 Oct 2023
- Registered enrollment
- 12
- Registry id
- NCT02659800
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.